Category: by journal

Novartis Diovan scandal claims two more papers

diabetes careA complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.

Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.

Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”

Continue reading Novartis Diovan scandal claims two more papers

Scientists, do you feel bullied by critics? These chemists do

eaton
Bruce Eaton, via UC-Boulder
feldheim
Daniel Feldheim, via UC-Boulder

A new site, Stand Up 2 Science Bullies, launched last week:

www.standup2sciencebullies.com is a forum for scientists to share their experience and provide advice pertaining to scientific bullying.  We welcome questions and comments from all scientists including students, faculty, and members of industry.  We sincerely hope that this forum will serve as an informative resource for scientists who feel that they are being treated unfairly by other scientists.

Continue reading Scientists, do you feel bullied by critics? These chemists do

RIKEN finds two “instances of research misconduct” in STAP stem cell work

rikenJapan’s RIKEN research center has found misconduct in work that led to two controversial Nature papers, purporting to show an easy way to create stem cells, that have been dogged by criticism for months.

Here’s an excerpt from today’s statement about “six items [RIKEN] has been investigating:”

Continue reading RIKEN finds two “instances of research misconduct” in STAP stem cell work

Duplication in physics journal questions key tenet of quantum mechanics

cmpHere’s a physics question: How is it possible to be in two places at the same time?

Answer: Submit the same manuscript twice and hope the editors forget to feed Schrödinger’s cat.

The journal Condensed Matter Physics is retracting a 2013 paper by a Ukrainian scientist who’d published essentially the same paper seven years earlier.The article was titled “On the origin of power-law distributions in systems with constrained phase space,” and was written by an E.V. Vakarin, of the Institute for Condensed Matter Physics, in Lviv UMR 7575 LECA ENSCP-UPMC-CNRS.

According to the abstract: Continue reading Duplication in physics journal questions key tenet of quantum mechanics

Regenerative medicine, regenerative publishing

devbioDevelopmental Biology has retracted a 2009 paper by an group of regenerative medicine specialists who, it seems, were regenerating more than just cells.

The article, titled “The human placenta is a hematopoietic organ during the embryonic and fetal periods of development,” was led by Susan Fisher, of the Institute for Regenerative Medicine at the University of California, San Francisco. It has been cited 32 times, according to Thomson Scientific’s Web of Knowledge.

According to the abstract: Continue reading Regenerative medicine, regenerative publishing

Some authors seem to cite their own retracted studies. Should we be concerned?

sci eng ethicsSome authors of retracted studies persist in citing their retracted work, according to a new study in Science and Engineering Ethics that calls the trend “very concerning.”

Continue reading Some authors seem to cite their own retracted studies. Should we be concerned?

Bogus Western blots lead to retraction of cancer paper

ejpharmA group of Italian researchers has retracted their 2013 paper on colorectal cancer because one of the authors, they, say, was tinkering with the data.

The article, “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines,” appeared in the European Journal of Pharmacology in August. The first author was Giuseppina Gangemi, of the University of Salerno.

The paper purported to find that:

Continue reading Bogus Western blots lead to retraction of cancer paper

Neurosurgery journal retracts spine paper for lack of attribution

bjneurosurgA neurosurgeon in the UK has lost his 2013 paper on spinal surgery in the British Journal of Neurosurgery for doing what appears to have been an end-run around the folks that did the work.

The article, “The management of spinal dural fistulas: a 13-year retrospective analysis,” was written by Denosshan Sri, of Addenbrooke’s Hospital, in Cambridge.

Here’s the abstract:

Continue reading Neurosurgery journal retracts spine paper for lack of attribution

“Unable to dispel the doubts,” authors lose protein structure paper

ebjA suggestion: If you’re going to use the words “overestimated accuracy” in the title of your paper, you’d better make sure you aren’t guilty of the same yourself.

A group of authors in China has lost their June 2013 paper in the European Biophysics Journal because they appear to have misinterpreted their data.  The paper, “Overestimated accuracy of circular dichroism in determining protein secondary structure,” came from chemists at Fudan University in Shanghai, and purported to find that:

Continue reading “Unable to dispel the doubts,” authors lose protein structure paper

Late resveratrol researcher Dipak Das up to 20 retractions

Das, via UConn
Das, via UConn

Dipak Das, the former University of Connecticut researcher found to have committed more than 100 counts of misconduct, and who passed away last year, has had another retraction appear.

Here’s the notice, for “Dynamic Action of Carotenoids in Cardioprotection and Maintenance of Cardiac Health,” from Molecules:

Continue reading Late resveratrol researcher Dipak Das up to 20 retractions